Modeling the interactions of herbal drugs to beta-ketoacyl ACP synthase of Mycobacterium tuberculosis H37Rv. 2008

K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
Center for Postgraduate Studies, Sri Bhagawan Mahaveer Jain College, 18/3, 9th Main, Jayanagar 3rd Block, Bangalore-560011.

The present paper reports a bio-computational study carried out with the aim of understanding the binding mode of anti-TB herbal ligands onto the homology modeled structure of fatty acid synthase of Mycobacterium tuberculosis (M.tb) H37Rv. Sequence alignment of beta-ketoacyl ACP synthase (KAS) domain of the protein with other related KAS sequences of PDB database revealed high degree of sequence variation. However, the catalytic triad comprising of CHH (cys150-his279-his320) was found to be conserved in the KAS sequence of M.tb H37Rv. The tertiary structure of this protein predicted using genetic algorithm operator in the MODELLER package appeared to give a satisfactory structure for the purpose of studying ligand and substrate binding pockets on the protein. PDB templates complexed with ligands (citric acid and lauric acid) were used for model building. Docking studies carried out with different herbal ligands suggest that, aloe-emodin and nimbin are the best herbal candidates to replace the synthetic drugs 'thiolactomycin/cerulenin'.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
June 1998, Science (New York, N.Y.),
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
January 2009, PloS one,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
January 2011, Current medicinal chemistry,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
June 2002, The Biochemical journal,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
October 2006, Biochemistry,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
June 2001, The Journal of biological chemistry,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
June 2011, Indian journal of biochemistry & biophysics,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
February 2007, Protein science : a publication of the Protein Society,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
March 2001, The Journal of biological chemistry,
K V Ramesh, and Mitali Purohit, and K Mekhala, and Mrinalini Krishnan, and Kaushiki Wagle, and Sudha Deshmukh
January 2008, Methods in molecular medicine,
Copied contents to your clipboard!